Sorrento Therapeutics Announces the FDA IND Clearance of STI-1558, An Oral M(pro) and Cathepsin L Inhibitor to Treat COVID-19 Read more
Avista Therapeutics Partners with Roche to Develop Next-Generation AAV Gene Therapy Vectors for Ocular Diseases Read more
Gilead Sciences Signs New Joint Procurement Agreement with the European Commission for Veklury (Remdesivir) Read more
Nabriva Therapeutics Expands XENLETA (lefamulin) Presence with Exclusive Agreement with Er-Kim Pharmaceuticals Read more
AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF ZONISADE (zonisamide oral suspension) Read more
AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine Read more
Incyte Announces FDA Approval of Opzelura (ruxolitinib) Cream for the Treatment of Vitiligo Read more
Amylyx Pharmaceuticals Announces Partnership Agreement with Sunnybrook Research Institute to Identify Novel Drug Candidates for Neurodegenerative Diseases Read more
Therapeutic Goods Administration Grants Provisional Approval for Moderna’s COVID-19 Vaccine in Children Aged Six Months to Five Years Read more
Everest Medicines Announces European Commission Grants Approval of Kinpeygo® for Adults with Primary IgA Nephropathy to our Partner Calliditas Therapeutics Read more